{"data":{"id":"us-in/ic-16-42-26-1","jurisdiction":"us-in","citation":"IC 16-42-26-1","heading":"Effect on clinical trial laws; availability","body":"Sec. 1. (a) This chapter does not affect IC 5-10-8-15, IC 12-15-5-9.2, IC 27-8-25, or IC 27-13-7-20.2.\n(b) This chapter does not require a manufacturer to make available any investigational drug, biological product, or device.","path":["TITLE 16. HEALTH","ARTICLE 42. REGULATION OF FOOD, DRUGS, AND COSMETICS","Chapter 26. Drugs: Investigational Drug, Biological Product, or Device"],"source_url":"https://iga.in.gov/ic/2026/Title_16.html#16-42-26-1","current_through":"2026","vintage":"2026","retrieved_at":"2026-09-11T20:02:18Z","sha256":"2f22d7351365a90942cb888c751eaf2381ac6c1c9145bc050c0015a4ebd68552","source_id":"us-in","stale":false,"prev":"us-in/ic-16-42-25-8","next":"us-in/ic-16-42-26-2"},"notice":"GroundRules: Original legal text. Not legal advice."}